Market Closed -
Toronto S.E.
16:00:00 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
12.15
CAD
|
+2.45%
|
|
+11.37%
|
+79.73%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
19,873
|
7,154
|
15,424
|
3,737
|
1,215
|
898.7
|
-
|
-
|
Enterprise Value (EV)
1 |
18,338
|
5,643
|
14,708
|
3,866
|
1,739
|
1,326
|
1,302
|
898.7
|
P/E ratio
|
-22.5
x
|
-5.38
x
|
-8.61
x
|
-12.3
x
|
-0.34
x
|
-2.09
x
|
-9.07
x
|
-10.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
87.8
x
|
17.9
x
|
28.2
x
|
7.18
x
|
3.02
x
|
2.8
x
|
2.98
x
|
2.79
x
|
EV / Revenue
|
81
x
|
14.2
x
|
26.9
x
|
7.43
x
|
4.32
x
|
4.14
x
|
4.31
x
|
2.79
x
|
EV / EBITDA
|
-71.4
x
|
-12.7
x
|
-43.2
x
|
-9.31
x
|
-4.97
x
|
-14
x
|
-93.5
x
|
-39.8
x
|
EV / FCF
|
-15.7
x
|
-3.82
x
|
-23.3
x
|
-6.64
x
|
-3.07
x
|
-6.14
x
|
-11.1
x
|
-44.1
x
|
FCF Yield
|
-6.35%
|
-26.2%
|
-4.28%
|
-15.1%
|
-32.6%
|
-16.3%
|
-9.01%
|
-2.27%
|
Price to Book
|
2.22
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
34,371
|
34,965
|
38,216
|
39,417
|
51,264
|
73,965
|
-
|
-
|
Reference price
2 |
578.2
|
204.6
|
403.6
|
94.80
|
23.70
|
12.15
|
12.15
|
12.15
|
Announcement Date
|
19-06-20
|
20-05-29
|
21-06-01
|
22-05-27
|
23-06-22
|
-
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
226.3
|
398.8
|
546.6
|
520.3
|
402.9
|
320.4
|
302
|
321.6
|
EBITDA
1 |
-257
|
-442.8
|
-340.3
|
-415.4
|
-349.7
|
-94.52
|
-13.92
|
-22.61
|
EBIT
1 |
-577
|
-1,046
|
-1,134
|
-713.3
|
-2,848
|
-179.3
|
-93.36
|
-87.56
|
Operating Margin
|
-254.94%
|
-262.23%
|
-207.44%
|
-137.09%
|
-706.94%
|
-55.97%
|
-30.92%
|
-27.23%
|
Earnings before Tax (EBT)
1 |
-657.8
|
-1,509
|
-1,684
|
-329.4
|
-3,314
|
-480.7
|
-149.5
|
-149.1
|
Net income
1 |
-685.4
|
-1,321
|
-1,745
|
-302.2
|
-3,278
|
-491.2
|
-120.9
|
-113.1
|
Net margin
|
-302.83%
|
-331.35%
|
-319.2%
|
-58.08%
|
-813.63%
|
-153.32%
|
-40.04%
|
-35.16%
|
EPS
2 |
-25.70
|
-38.00
|
-46.90
|
-7.700
|
-70.70
|
-5.823
|
-1.340
|
-1.178
|
Free Cash Flow
1 |
-1,165
|
-1,478
|
-630.2
|
-582.5
|
-566.8
|
-215.8
|
-117.2
|
-20.38
|
FCF margin
|
-514.7%
|
-370.53%
|
-115.29%
|
-111.95%
|
-140.67%
|
-67.36%
|
-38.82%
|
-6.34%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-06-20
|
20-05-29
|
21-06-01
|
22-05-27
|
23-06-22
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
131.4
|
141
|
111.8
|
110.1
|
117.9
|
101.2
|
87.54
|
108.7
|
69.6
|
90.06
|
72.51
|
74.61
|
71.81
|
78.19
|
77.79
|
EBITDA
1 |
-162.6
|
-67.41
|
-121.8
|
-74.8
|
-78.1
|
-87.5
|
-95.64
|
-57.84
|
-11.86
|
-8.989
|
-11.96
|
-0.7081
|
0.0695
|
3.083
|
1.174
|
EBIT
1 |
-215.4
|
-150
|
-288.5
|
-110.2
|
-175.8
|
-153.8
|
-604.7
|
-87.48
|
-36.9
|
-60.32
|
-24.63
|
-24.67
|
-23.44
|
-20.11
|
-16.6
|
Operating Margin
|
-163.93%
|
-106.38%
|
-258.12%
|
-100.12%
|
-149.2%
|
-151.92%
|
-690.82%
|
-80.45%
|
-53.02%
|
-66.97%
|
-33.97%
|
-33.07%
|
-32.65%
|
-25.72%
|
-21.34%
|
Earnings before Tax (EBT)
1 |
-19.54
|
-115.7
|
-587.1
|
-2,084
|
-223.7
|
-267.1
|
-664
|
-39.84
|
-135.3
|
-231.4
|
-32.09
|
-24.7
|
-24.33
|
-21.01
|
-16.6
|
Net income
1 |
-11.06
|
-108.9
|
-574.6
|
-2,083
|
-221.8
|
-261.6
|
-640.1
|
-38.12
|
-310
|
-216.8
|
-39.27
|
-27.06
|
-26.23
|
-24.59
|
-16.46
|
Net margin
|
-8.42%
|
-77.27%
|
-514.11%
|
-1,891.79%
|
-188.19%
|
-258.45%
|
-731.23%
|
-35.06%
|
-445.45%
|
-240.72%
|
-54.15%
|
-36.27%
|
-36.52%
|
-31.44%
|
-21.16%
|
EPS
2 |
-0.3000
|
-2.800
|
-14.60
|
-52.30
|
-4.700
|
-5.400
|
-12.80
|
-0.7000
|
-4.300
|
-2.620
|
-0.4320
|
-0.3467
|
-0.3300
|
-0.2833
|
-0.1633
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-05
|
22-02-09
|
22-05-27
|
22-08-05
|
22-11-09
|
23-02-09
|
23-06-22
|
23-08-09
|
23-11-09
|
24-02-09
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
129
|
524
|
427
|
403
|
-
|
Net Cash position
1 |
1,535
|
1,511
|
716
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-0.3113
x
|
-1.499
x
|
-4.517
x
|
-28.96
x
|
-
|
Free Cash Flow
1 |
-1,165
|
-1,478
|
-630
|
-582
|
-567
|
-216
|
-117
|
-20.4
|
ROE (net income / shareholders' equity)
|
-16.9%
|
-21.7%
|
-27.3%
|
-8.55%
|
-151%
|
-55.5%
|
-10.7%
|
-5.5%
|
ROA (Net income/ Total Assets)
|
-13.5%
|
-17.1%
|
-17.2%
|
-4.86%
|
-81.5%
|
-8.8%
|
-5.4%
|
-3.4%
|
Assets
1 |
5,084
|
7,711
|
10,167
|
6,219
|
4,022
|
5,582
|
2,239
|
3,325
|
Book Value Per Share
|
260.0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-19.50
|
-22.20
|
-12.50
|
-
|
-12.00
|
-1.610
|
0.2300
|
-0.0700
|
Capex
1 |
644
|
705
|
165
|
36.7
|
9.22
|
7
|
6.06
|
9.54
|
Capex / Sales
|
284.73%
|
176.78%
|
30.09%
|
7.05%
|
2.29%
|
2.18%
|
2.01%
|
2.97%
|
Announcement Date
|
19-06-20
|
20-05-29
|
21-06-01
|
22-05-27
|
23-06-22
|
-
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
12.15
CAD Average target price
6.392
CAD Spread / Average Target -47.39% Consensus |
1st Jan change
|
Capi.
|
---|
| +79.73% | 656M | | +35.04% | 5.92B | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | -7.89% | 1.68B | | +0.09% | 1.65B | | -12.97% | 1.53B |
Alternative Medicine
|